GelMEDIX has filed a notice of an exempt offering of securities to raise $3,500,000.00 in New Debt Financing.
According to filings with the U.S. Securities and Exchange Commission, GelMEDIX is raising up to $3,500,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Jeffrey Behrens played a key…